Viewing Study NCT04990466


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2026-02-02 @ 6:43 AM
Study NCT ID: NCT04990466
Status: WITHDRAWN
Last Update Posted: 2024-01-19
First Post: 2021-08-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.
Sponsor: NeuroRx, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None SARS-CoV-2 View
None Delta Variant View
None BRILIFE View
None VSV-ΔG View